Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Stephanie Chen, Sarowar Golam, Julie Myers, Chris Bly, Harry Smolen & Xiao Xu. (2018) Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Current Medical Research and Opinion 34:12, pages 2075-2088.
Read now
Read now
Andriana I. Papaioannou, Konstantinos Kostikas, Petros Bakakos, Anastasia Papaporfyriou, Elissavet Konstantellou, Georgios Hillas, Georgios Papatheodorou, Nikolaos G. Koulouris, Spyridon Papiris & Stelios Loukides. (2016) Predictors of future exacerbation risk in patients with asthma. Postgraduate Medicine 128:7, pages 687-692.
Read now
Read now
Claire E. Hayes, Henry J. Nuss, Tung-Sung Tseng & Sarah Moody-Thomas. (2015) Use of asthma control indicators in measuring inhaled corticosteroid effectiveness in asthmatic smokers: a systematic review. Journal of Asthma 52:10, pages 996-1005.
Read now
Read now
Anne B. Taegtmeyer, C. Steurer-Stey, David B. Price, J.H. Wildhaber, F. Spertini & Jörg D. Leuppi. (2009) Predictors of asthma control in everyday clinical practice in Switzerland. Current Medical Research and Opinion 25:10, pages 2549-2555.
Read now
Read now
Articles from other publishers (18)
Sophie Graff, Guy Brusselle, Shane Hanon, Carine Sohy, Lieven Dupont, Rudy Peche, Alain Michils, Charles Pilette, Guy Joos, Lies Lahousse, Therese Lapperre, Renaud Louis & Florence Schleich. (2022) Anti–Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry. The Journal of Allergy and Clinical Immunology: In Practice 10:2, pages 467-477.
Crossref
Crossref
Alice M. Cottee, Leigh M. Seccombe, Cindy Thamrin, Gregory G. King, Matthew J. Peters & Claude S. Farah. (2020) Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry. Chest 157:6, pages 1435-1441.
Crossref
Crossref
Ioana Agache, Yang Song, Claudio Rocha, Jessica Beltran, Margarita Posso, Corinna Steiner, Pablo Alonso‐Coello, Cezmi Akdis, Mubeccel Akdis, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Carlos Canelo‐Aybar, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1058-1068.
Crossref
Crossref
Ioana Agache, Claudio Rocha, Jessica Beltran, Yang Song, Margarita Posso, Ivan Solà, Pablo Alonso‐Coello, Cezmi Akdis, Mubeccel Akdis, Giorgio W. Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano Del Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Jurgen Schwarze, Carlos Canelo‐Aybar, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1043-1057.
Crossref
Crossref
Ioana Agache, Jessica Beltran, Cezmi Akdis, Mubeccel Akdis, Carlos Canelo‐Aybar, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano Del Giacco, Thomas Eiwegger, Davide Firinu, James E. Gern, Eckard Hamelmann, Nicola Hanania, Mika Mäkelä, Irene Hernández‐Martín, Parameswaran Nair, Liam O'Mahony, Nikolaos G. Papadopoulos, Alberto Papi, Hae‐Sim Park, Luis Pérez de Llano, Margarita Posso, Claudio Rocha, Santiago Quirce, Joaquin Sastre, Mohamed Shamji, Yang Song, Corinna Steiner, Jurgen Schwarze, Pablo Alonso‐Coello, Oscar Palomares & Marek Jutel. (2020) Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Allergy 75:5, pages 1023-1042.
Crossref
Crossref
Amelia Lorensia, Rivan Virlando Suryadinata & Richa Ratnasari. (2019) GAMBARAN PERSEPSI PENYAKIT TERHADAP KESEHATAN FUNGSI PARU PADA PASIEN ASMA DI SURABAYA. The Indonesian Journal of Public Health 14:2, pages 263.
Crossref
Crossref
Patrick W. Sullivan, Vahram H. Ghushchyan, Jessica Marvel, Yu Chen Barrett & Anne L. Fuhlbrigge. (2019) Association Between Pulmonary Function and Asthma Symptoms. The Journal of Allergy and Clinical Immunology: In Practice 7:7, pages 2319-2325.
Crossref
Crossref
Sarah E. Davies, Abigail Bishopp, Simon Wharton, Alice M. Turner & Adel H. Mansur. (2018) Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review. Respiratory Medicine 143, pages 18-30.
Crossref
Crossref
Rachel Knightly, Stephen J Milan, Rodney Hughes, Jennifer A Knopp-Sihota, Brian H Rowe, Rebecca Normansell & Colin Powell. (2017) Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database of Systematic Reviews 2017:11.
Crossref
Crossref
Antoni Sicras-Mainar, Jesús I. Diago-Cabezudo, Guadalupe Sánchez-Herrero, Ruth Navarro-Artieda & Manuel García-Losa. (2016) Carga de la enfermedad y costes asociados del asma no grave en adultos en España: análisis de datos de una comunidad representativa. PharmacoEconomics Spanish Research Articles 13:3, pages 113-119.
Crossref
Crossref
Sarah Svenningsen, Parameswaran Nair, Fumin Guo, David G. McCormack & Grace Parraga. (2016) Is ventilation heterogeneity related to asthma control?. European Respiratory Journal 48:2, pages 370-379.
Crossref
Crossref
Enrico Heffler, Claudia Crimi, Raffaele Campisi, Stefania Sichili, Giuliana Nicolosi, Morena Porto, Rossella Intravaia, Maria Eva Sberna, Maria Teresa Liuzzo & Nunzio Crimi. (2016) Bronchodilator response as a marker of poor asthma control. Respiratory Medicine 112, pages 45-50.
Crossref
Crossref
Vanessa J. KellyScott A. SandsR. Scott HarrisJose G. VenegasNathan J. Brown, Christopher R. Stuart-AndrewsGregory G. King & Bruce R. Thompson. (2013) Respiratory system reactance is an independent determinant of asthma control. Journal of Applied Physiology 115:9, pages 1360-1369.
Crossref
Crossref
Joseph R. Arron, Heleen Scheerens & John G. Matthews. 2013. Immunopharmacology. Immunopharmacology
1
49
.
Geoff K. Frampton & Jonathan Shepherd. (2010) Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs. Quality of Life Research 20:3, pages 343-357.
Crossref
Crossref
Helen K. Reddel, D. Robin Taylor, Eric D. Bateman, Louis-Philippe Boulet, Homer A. Boushey, William W. Busse, Thomas B. Casale, Pascal Chanez, Paul L. Enright, Peter G. Gibson, Johan C. de Jongste, Huib A. M. Kerstjens, Stephen C. Lazarus, Mark L. Levy, Paul M. O'Byrne, Martyn R. Partridge, Ian D. Pavord, Malcolm R. Sears, Peter J. Sterk, Stuart W. Stoloff, Sean D. Sullivan, Stanley J. Szefler, Mike D. Thomas & Sally E. Wenzel. (2009) An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations. American Journal of Respiratory and Critical Care Medicine 180:1, pages 59-99.
Crossref
Crossref
R. H. Dougherty & J. V. Fahy. (2009) Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clinical & Experimental Allergy 39:2, pages 193-202.
Crossref
Crossref
Michael Schatz. 2009. Allergy Frontiers: Diagnosis and Health Economics. Allergy Frontiers: Diagnosis and Health Economics
507
541
.